Feng Mu

Feng Mu

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2023 in Nature Machine Intelligence
Verified
Journal Article
Closed access
PDF file
YWYi Wang
Yi Wang
HTHui Tang
Hui Tang
LHLichao Huang
Lichao Huang
LPLulu Pan
Lulu Pan
LYLixiang Yang
Lixiang Yang
MYMeng Yang
Meng Yang

25 August 2022 in Nature Machine Intelligence
Verified
Journal Article
Closed access
PDF file
MYMeng Yang
Meng Yang
YYYueyuxiao Yang
Yueyuxiao Yang
CXChenxi Xie
Chenxi Xie
MNMing Ni
Ming Ni
JLJian Liu
Jian Liu
JWJian Wang
Jian Wang

10 May 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MYMeng Yang
Meng Yang
LHLichao Huang
Lichao Huang
HHHaiping Huang
Haiping Huang
HTHui Tang
Hui Tang
NZNan Zhang
Nan Zhang
FMFeng Mu
Feng Mu
Interpretation of non-coding genome remains an unsolved challenge in human genetics due to impracticality of exhaustively annotating biochemically active elements in all conditions. Deep learning based computational approaches emerge recently to help interpret non-coding regions. Here, we present LOGO (Language of Genome), a self-attention based contextualized pre-trained language model containing only two self-attention layers with 1 million parameters as a substantially light architecture that applies self-supervision techniques to learn bidirectional representations of the unlabelled human reference genome. LOGO is then fine-tuned for sequence labelling task, and further extended to variant prioritization task via a special input encoding scheme of alternative alleles followed by adding a convolutional module. Experiments show that LOGO achieves 15% absolute improvement for promoter identification and up to 4.5% absolute improvement for enhancer-promoter interaction prediction. LOGO exhibits state-of-the-art multi-task predictive power on thousands of chromatin features with only 3% parameterization benchmarking against the fully supervised model, DeepSEA and 1% parameterization against a recent BERT-based DNA language model. For allelic-effect prediction, locality introduced by one dimensional convolution shows improved sensitivity and specificity for prioritizing non-coding variants associated with human diseases. In addition, we apply LOGO to interpret type 2 diabetes (T2D) GWAS signals and infer underlying regulatory mechanisms. We make a conceptual analogy between natural language and human genome and demonstrate LOGO is an accurate, fast, scalable, and robust framework to interpret non-coding regions for global sequence labeling as well as for variant prioritization at base-resolution.

29 August 2022 in Cell Systems
Verified
Journal Article
Closed access
MYMeng Yang
Meng Yang
CZChuwen Zhang
Chuwen Zhang
XWXiaoji Wang
Xiaoji Wang
XLXingmin Liu
Xingmin Liu
SLShisen Li
Shisen Li
FMFeng Mu
Feng Mu

19 July 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
YLYanling Liang
Yanling Liang
QXQumiao Xu
Qumiao Xu
SLSongming Liu
Songming Liu
JLJie Li
Jie Li
FWFei Wang
Fei Wang
LZLinnan Zhu
Linnan Zhu
T cell receptor-engineered T cells (TCR-Ts) have emerged as potent cancer immunotherapies. While most research focused on classical cytotoxic CD8+ T cells, the application of CD4+ T cells in adoptive T cell therapy has gained much interest recently. However, the cytotoxic mechanisms of CD4+ TCR-Ts have not been fully revealed. In this study, we obtained an MHC class I-restricted MART-127-35-specific TCR sequence based on the single-cell V(D)J sequencing technology, and constructed MART-127-35-specific CD4+ TCR-Ts and CD8+ TCR-Ts. The antitumor effects of CD4+ TCR-Ts were comparable to those of CD8+ TCR-Ts in vitro and in vivo. To delineate the killing mechanisms of cytotoxic CD4+ TCR-Ts, we performed single-cell RNA sequencing and found that classical granule-dependent and independent cytolytic pathways were commonly used in CD4+ and CD8+ TCR-Ts, while high expression of LTA and various costimulatory receptors were unique features for cytotoxic CD4+ TCR-Ts. Further signaling pathway analysis revealed that transcription factors Runx3 and Blimp1/Tbx21 were crucial for the development and killing function of cytotoxic CD4+ T cells. Taken together, we report the antitumor effects and multifaceted killing mechanisms of CD4+ TCR-Ts, and also indicate that MHC class I-restricted CD4+ TCR-Ts could serve as potential adoptive T cell therapies.

1 November 2019 in Annals of Palliative Medicine
Verified
Journal Article
Open access
PDF file
JCJibing Chen
Jibing Chen
XKXiaofeng Kong
Xiaofeng Kong
FMFeng Mu
Feng Mu
TLTianyu Lu
Tianyu Lu
DDDuanming Du
Duanming Du
KXKecheng Xu
Kecheng Xu
Three patients with nasopharyngeal carcinoma developed binaural secretory otitis media 12, 2, and 0.5 years after radiotherapy, respectively. The secretions subsided after conventional drug and drainage treatments, but hearing continued to deteriorate until severe loss was documented in both ears. After examination of the eardrum and tympanum, patients were enrolled in a clinical trial in the first half of 2019 (ClinicalTrials.gov: NCT03818347). After 0.5, 1 and 2 months of continuous hydrogen–oxygen therapy, our first three patients reported different levels of improvement in binaural hearing. This is the first report to show that, after treatment for nasopharyngeal carcinoma, hearing loss can be alleviated using hydrogen–oxygen therapy.